Sulfuric Acid

Sulfuric Acid

SCHEMBL7329510

CCS(=O)(=O)Nc1ccc2[nH]c(=O)n(CCCCN3CC=C(c4ccccc4)CC3)c(=O)c2c1.O=S(=O)(O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 3/20 0.48
TSHR P16473 2/20 0.48
ALOX15 P16050 2/20 0.48
USP2 O75604 1/20 0.48
HTT P42858 1/20 0.48
PARP1 P09874 7/20 0.47
HTR1A P08908 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
CYP2C19 P33261 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7287843 0.98 PARP1 (0.49) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7293124 0.90 PARP1 (0.50) KDM4ETDP1ALDH1A1MAPTHPGD
Hydrochloric Acid SCHEMBL7296451 0.89 PARP1 (0.49) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7297124 0.86 PARP1 (0.53) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7299614 0.83 KDM4E (0.49) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7297348 0.83 KDM4E (0.49) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7297272 0.80 KDM4E (0.63) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7289998 0.80 KDM4E (0.57) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7298716 0.80 PARP1 (0.58) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL7292780 0.80 PARP1 (0.55) KDM4ETDP1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5296487-A Dopamine antagonist for nervous system disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US disclosed
WO-1993018769-A2 A NEW USE OF QUINAZOLINE DERIVATIVE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-09-30 WO disclosed
WO-1993012794-A1 USE OF AN ANIMAZOLINE DERIVATIVE FOR THE TREATMENT OF GLAUCOMA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-07-08 WO disclosed